On 10 April 2024, the European Parliament adopted the two reports on the Revision of the EU General Pharmaceutical Legislation, namely the Directive on medicinal products for human use and the Regulation on authorisation and supervision of medicinal products for human use and governing rules… read more
on ENVI reports on the EU Pharmaceutical Package Today, 19 March 2024, the European Parliament’s Committee on the Environment, Public Health and Food Safety (ENVI) adopted the two reports on the so-called EU Pharmaceutical Package, namely the Directive on Medicinal products for human use and… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Enrico Piccinini, Head of Europe & International Rare Diseases, Chiesi Global Rare Diseases Enrico… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In August, we spoke with Shekhar Natarajan, Vice President – EU Regulatory Affairs, Dyne Therapeutics. Shekhar Natarajan is Vice President-… read more
EUCOPE’s Sounds of Science Podcast – Episode 17 Real-World Evidence (RWE): The need for a multi-stakeholder approach Within the EU, the life sciences industry requires a strong innovation framework across the patient journey so that such technological advancements can be used to the benefit of… read more
On 7 July, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs – hosted the second episode of its Life Science Lectures webinar series. The focus of the webinar, titled ‘’Defining (high) unmet medical need: will it steer innovation towards filling existing gaps?’’, was to dive… read more
EUCOPE’S Sounds of Science Podcast – Episode 16 Rare Reflections: Impact of the OMP revision on rare disease companies in Europe On 26 April 2023, the European Commission published its long awaited proposal revising the foundational pharmaceutical legislation, including the Orphan Medicinal Products (OMP) Regulation…. read more
On 30 May, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the inaugural episode of its Life Science Lectures webinar series, “Attaching conditionalities to incentives: the right path to improve access?” The episode delved into the incentive system outlined in the EU Pharmaceutical Package,… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In March, we spoke with Adam Plich, Founder and CEO of Avanzanite Bioscience B.V. Adam Andrzej Plich is the… read more
Sounds of Science Podcast – Episode 13 Rare Disease Day 2023: Improving equitable access and diagnosis for people living with a rare disease Between 27 and 36 million Europeans experience living with a rare disease. Every Rare Disease Day – taking place on 28 February… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View